Synthesis of some novel pyrano[2,3-f]chromenone derivatives
详细信息    查看全文
  • 作者:Babak Heidary Alizadeh (1)
    Mina Saeedi (2)
    Gholamreza Dehghan (3)
    Alireza Foroumadi (2)
    Abbas Shafiee (2)

    1. Iranian Research Institute of Plant Protection (IRIPP)
    ; Shahid Chamran Avenue ; Yaman St. No 1 ; PO. Box ; 1454 ; Tehran ; Iran
    2. Department of Medicinal Chemistry
    ; Faculty of Pharmacy and Pharmaceutical Sciences Research Center ; Tehran University of Medical Sciences ; 14176 ; Tehran ; Iran
    3. Department of Biology
    ; Faculty of Natural Science ; University of Tabriz ; Tabriz ; Iran
  • 关键词:Pyranochromenone ; Resorcinol ; Claisen rearrangement
  • 刊名:Journal of the Iranian Chemical Society
  • 出版年:2015
  • 出版时间:April 2015
  • 年:2015
  • 卷:12
  • 期:4
  • 页码:605-612
  • 全文大小:419 KB
  • 参考文献:1. J. Hepworth, in / Comprehensive Heterocyclic Chemistry, ed. by A.R. Katrizky, C.W. Rees (Pergamon, Oxford, 1984), vol. 3, p. 737
    2. S.V. Laxmi, Y.T. Reddy, B.S. Kuarm, P.N. Reddy, P.A. Crooks, B. Rajitha, Bioorg. Med. Chem. Lett. 21, 4329 (2011) CrossRef
    3. M. Volgraf, L. Chan, M.P. Huestis, H.E. Purkey, M. Burkard, M.G. Do, J. Harris, K.W. Hunt, X. Liu, J.P. Lyssikatos, S. Rana, A.A. Thomas, G.P.A. Vigers, M. Siu, Bioorg. Med. Chem. Lett. 24, 2477 (2014) CrossRef
    4. Y.L. Murthy, K.P. Suhasini, A.S. Pathania, S. Bhushan, Y.N. Sastry, Eur. J. Med. Chem. 62, 545 (2013) CrossRef
    5. J.A. Makawana, M.P. Patel, R.G. Patel, Arch. Pharm. 345, 314 (2012) CrossRef
    6. C. Gerh盲user, W. Mar, S.K. Lee, N. Suh, Y. Luo, J. Kosmeder, L. Luyengi, H.H.S. Fong, A.D. Kinghorn, R.M. Moriarty, R.G. Mehta, A. Constantinou, R.C. Moon, J.M. Pezzuto, Nat. Med. 1, 260 (1995) CrossRef
    7. T. Fukai, T. Nomura, Phytochemistry 38, 759 (1995) CrossRef
    8. J.K. Kim, J.S. Oh, J.K. Lee, J. Korean Soc. Appl. Biol. Chem. 56, 541 (2013) CrossRef
    9. G.O. Udeani, C. Gerh盲user, C.F. Thomas, R.C. Moon, J.W. Kosmeder, A.D. Kinghorn, R.M. Moriarty, J.M. Pezzuto, Cancer Res. 57, 3424 (1997)
    10. R.L. Farmer, K.A. Scheidt, Chem. Sci. 4, 3304 (2013) CrossRef
    11. D.J. Chang, H. An, K.S. Kim, H.H. Kim, J. Jung, J.M. Lee, N.J. Kim, Y.T. Han, H. Yun, S. Lee, G. Lee, S. Lee, J.S. Lee, J.H. Cha, J.H. Park, J.W. Park, S.C. Lee, S.G. Kim, J.H. Kim, H.Y. Lee, K.W. Kim, Y.G. Suh, J. Med. Chem. 55, 10863 (2012) CrossRef
    12. V. Thamilselvan, M. Menon, S. Thamilselvan, Int. J. Cancer 129, 2916 (2011) CrossRef
    13. K.H. Chun, J.W. Kosmeder II, S. Sun, J.M. Pezzuto, R. Lotan, W.K. Hong, H.Y. Lee, J. Natl. Cancer Inst. 95, 291 (2003) CrossRef
    14. H.Y. Lee, S.H. Oh, J.K. Woo, W.Y. Kim, C.S.V. Pelt, R.E. Price, D. Cody, H. Tran, J.M. Pezzuto, R.M. Moriarty, W.K. Hong, J. Natl. Cancer Inst. 97, 1695 (2005) CrossRef
    15. G. Murillo, X. Peng, K.E. Torres, R.G. Mehta, Cancer Prev. Res. 2, 942 (2009) CrossRef
    16. Y.A. Suh, J.H. Kim, M.A. Sung, H.J. Boo, H.J. Yun, S.H. Lee, H.J. Lee, H.Y. Min, Y.G. Suh, K.W. Kim, H.Y. Lee, Cancer Lett. 332, 102 (2013) CrossRef
    17. W.Y. Kim, D.J. Chang, B. Hennessy, H.J. Kang, J. Yoo, S.H. Han, Y.S. Kim, H.J. Park, S.Y. Seo, G. Mills, K.W. Kim, W.K. Hong, Y.G. Suh, H.Y. Lee, Cancer Prev. Res. 1, 577 (2008) CrossRef
    18. A. Foroumadi, S. Emami, M. Sorkhi, M. Nakhjiri, Z. Nazarian, S. Heydari, S.K. Ardestani, F. Poorrajab, A. Shafiee, Chem. Biol. Drug Des. 75, 590 (2010) CrossRef
    19. L. Firoozpour, N. Edraki, M. Nakhjiri, S. Emami, M. Safavi, S.K. Ardestani, M. Khoshneviszadeh, A. Shafiee, A. Foroumadi, Arch. Pharmacal Res. 35, 2117 (2012) CrossRef
    20. A. Fallah-Tafti, R. Tiwari, A.N. Shirazi, T. Akbarzadeh, D. Mandal, A. Shafiee, K. Parang, A. Foroumadi, Med. Chem. 7, 466 (2011) CrossRef
    21. A. Foroumadi, A. Samzadeh-Kermani, S. Emami, G. Dehghan, M. Sorkhi, F. Arabsorkhi, M.R. Heidari, M. Abdollahi, A. Shafiee, Bioorg. Med. Chem. Lett. 17, 6764 (2007) CrossRef
    22. T. Mosmann, J. Immunol. Methods 65, 55 (1983) CrossRef
    23. J.D. Godfrey Jr, R.H. Mueller, T.C. Sedergran, N. Soundararajan, V.J. Colandrea, Tetrahedron Lett. 35, 6405 (1994) CrossRef
    24. B.H. Alizadeh, A. Foroumadi, S. Emami, M. Khoobi, F. Panah, S.K. Ardestani, A. Shafiee, Eur. J. Med. Chem. 45, 5979 (2010) CrossRef
  • 刊物主题:Analytical Chemistry; Inorganic Chemistry; Physical Chemistry; Biochemistry, general; Organic Chemistry;
  • 出版者:Springer Berlin Heidelberg
  • ISSN:1735-2428
文摘
A new series of pyrano[2,3-f]chromenone derivatives were synthesized starting from resorcinol. Resorcinol reacted with 3-chloropropanoic acid to give 7-hydroxychroman-4-one and reaction of the later compound with 2-methylbut-3-yn-2-ol led to the formation of 7-((2-methylbut-3-yn-2-yl)oxy)chroman-4-one. The obtained compound tolerated the cyclization reaction through Claisen rearrangement by heating in DMF to afford 8,8-dimethyl-2,3-dihydro-4H,8H-pyrano[2,3-f]chromen-4-one. Reaction of the later compound with various aromatic aldehydes gave the title compounds in good yields. All products were evaluated for their cytotoxic activity on the blood tumor cell line K562 and compared to reference drug, etoposide. Most of them exhibited low inhibitory activity against tumor cell line and among them, the compound possessing three methoxy groups on aromatic ring showed better cytotoxic effect.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700